Last update 24 Mar 2025

LCB-71

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
ABL-202, CS-5001, LCB 71
+ [1]
Target
Action
antagonists
Mechanism
ROR1 antagonists(Inactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
Boost your research with our ADC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lymphoblastic LeukemiaPhase 1-14 Jul 2022
Mantle-Cell LymphomaPhase 1-14 Jul 2022
Non-Small Cell Lung CancerPhase 1-14 Jul 2022
Triple Negative Breast CancerPhase 1-14 Jul 2022
Advanced LymphomaPhase 1
United States
28 Mar 2022
Advanced LymphomaPhase 1
United States
28 Mar 2022
Advanced LymphomaPhase 1
China
28 Mar 2022
Advanced LymphomaPhase 1
Australia
28 Mar 2022
Advanced LymphomaPhase 1
Australia
28 Mar 2022
Advanced Malignant Solid NeoplasmPhase 1
United States
28 Mar 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NEWS
ManualManual
Phase 1
-
(B细胞非霍奇金淋巴瘤)
nuqfyvbuqj(dnarlkpnfm) = wkhdcekbni iuvlymyevw (rmrfsnuudc )
Positive
19 Dec 2024
(霍奇金淋巴瘤)
nuqfyvbuqj(dnarlkpnfm) = xbfumcvnoy iuvlymyevw (rmrfsnuudc )
Phase 1
33
(B-cell lymphoma)
bdoejhfddx(mieegdsfha) = xivszawjgd qpqfbtewoa (ornnuvebka )
Positive
09 Dec 2024
(霍奇金淋巴瘤)
bdoejhfddx(mieegdsfha) = lsiknrqbet qpqfbtewoa (ornnuvebka )
Phase 1
23
yddurknhhw(frnpfdsvwi) = none shakfrkskn (dscudggqrp )
Positive
07 Dec 2024
(Hodgkin lymphoma)
Phase 1
49
eksxpxzwap(idifxmymgt) = cylkjxutqo zcdplewfoo (flgajtabar )
Positive
24 May 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free